Elon Musk is an advocate of weight-loss drugs like Ozempic. Photo: X Zepbound: Contains tirzepatide, which is a dual agonist ...

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without ...

Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...

Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

On Jan. 1, North Dakota became the first state in the country where access to drugs like Wegovy is part of the EHB package. About 55,293 of North Dakota's 784,000 residents had coverage through fully ...

From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech ...

“The proliferation of counterfeit and other unsafe, unapproved tirzepatide knockoffs is dangerous ... Anyone who buys a GLP-1 drug without a prescription could be at risk of getting a ...

Next-gen obesity biotech Metsera has filed to debut on the public markets, proposing an IPO nine months after emerging. | ...

Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...